Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF and Frankfurt:6BX) (the “Company” or “Relevium”), announces its intention to create a…

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that the company…

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), announced today it has executed an…

Leveraging Cannabinoids in Pediatric Medicine

Research into the therapeutic benefits of cannabis is prompting a paradigm shift in many sectors of…

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSXV:RLV,  OTCQB:RLLVF and Frankfurt:6BX (the…

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix…

Relevium Closes Private Placement Financing

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it…

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to provide a corporate…

Relevium Acquires Exclusive Licence From California Based Cannakids®

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its…

Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision

Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX)(the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a…